Akademischer Bericht 2002 - Rheumaklinik - UniversitätsSpital Zürich

- 34 -
12. Masuda K, Masuda R, Neidhart M, Simmen BR, Michel BA, Müller-Ladner U, Gay
RE, Gay S: Molecular profile of synovial fibroblasts in rheumatoid arthritis depends
on the stage of proliferation. Arthritis Res 4:R8:1-7, 2002.
http://arthritis-research.com4/5/R8
13. Alexander D, Judex M, Meyringer R, Weiss-Klemm M, Gay S, Müller-Ladner U,
Aicher WK. Transcription factor Egr-1 activates collagen expression in
immortalized fibroblasts or fibrosarcoma cells. Biol Chem 383:1845-1853, 2002
14. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE,
Michel BA, Brühlmann P, Müller-Ladner U, Gay S, Matucci-Cerinic M: Angiogenic
and angiostatic factors in systemic sclerosis: Increased levels of vascular endothelial
growth factor (VEGF) are a feature of earliest disease stages and are associated
with the absence of fingertip ulcers. Arthritis Res 4:R11, 2002.
15. Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Bechir M,
Spieker LE, Neidhart M, Michel BA, Gay RE, Lüscher TF, Gay S, Ruschitzka F: Antitumor
necrosis factor-alpha treatment improves endothelial function in patients with
rheumatoid arthritis. Circulation 106:2184-2187, 2002.
16. Neumann E, Judex M, Kullmann F, Grifka J, Robbins PD, Pap T, Gay RE, Evans
CH, Gay S, Scholmerich J, Müller-Ladner U: Inhibition of cartilage destruction by
double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther
9:508-519, 2002.
17. Seemayer CA, Kolb SA, Neidhart M, Ohshima S, Gay RE, Michel BA, Gay S, Boni J,
Schüpbach J: Absence of inducible retroviruses from synovial fibroblasts and
synovial fluid cells of patients with rheumatoid arthritis. Arthritis Rheum 46:2811-
2813, 2002.
18. Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkörner E, Schulthess
G. Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol
21:324-327, 2002.
19. Fransen J, Stucki G, van Riel PLCM. The merits of monitoring: should we follow all
our rheumatoid arthritis patients in daily practice? Rheumatology 41:601-604,
2002.
20. Huwiler H, Klipstein A. Structured and systematic clarification of burden at the
workplace by means of the Ergonomic Workplace Analysis. Physiotherapie 4-
02:22-5, 2002.
21. Knols R, Stappaerts KH, Fransen J, Uebelhart D, Aufdemkampe G: Isometric
strength measurement for muscle weakness in cancer patients. Reproducibility of
isometric muscle strength measurements with a hand-held pull-gauge
dynamometer in cancer patients. Support Care Cancer 10:430-438, 2002.
22. Niedermann K, Fransen J, Huber E, Uebelhart D, Steiner W. Einstellungen und
Arbeitsweisen von PhysiotherapeutInnen - Begleitevaluation zum Outcome-Projekt
(2000-2001). Fisio Active 7:4-13, 2002.
23. Steiner W, Ryser L, Huber E, Uebelhart D, Aeschlimann A, Stucki G: Use of the
ICF model as a clinical problem-solving tool in physical therapy and rehabilitation
medicine. Phys Ther 82:1098-1107, 2002.